The Neuropsychiatric Inventory (NPI) is a reliable tool developed to capture a large scope of neuropsychiatric symptoms.
NPI’s utility and applicability is global and show significant impact in clinical trials.
The NPI has traversed clinical symptomatology and neurobiological data to provide key insights into the pathophysiology of neurodegenerative disorders.
The Neuropsychiatric Inventory (NPI) has been utilized to assess neuropsychiatric symptoms that occur in patients with Alzheimer disease (AD) and other neurodegenerative disorders (NDD).
NPI has been instrumental in clinical research that required neuropsychiatric …
Join today for instant access to all PsychU content, events, and more!
Membership is free!
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.